Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02885077
Other study ID # 16149813.3.0000.5346
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2016
Est. completion date October 2018

Study information

Verified date October 2018
Source Universidade Federal de Santa Maria
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Even with the advances in clinical therapy and percutaneous interventions, coronary artery bypass grafting (CABG) is still widely used in the treatment of patients with coronary artery disease (CAD). However, it is a complex procedure that triggers important organic implications especially on pulmonary function. In relation to the treatment of patients undergoing CABG, the recovery is linked to the cardiac rehabilitation programs. These programs can also be associated with other muscle training measures, among these there is inspiratory muscle training (IMT). Most studies has been implemented moderate-intensity IMT daily, but there are few studies about the effects of high intensity training loads performed on alternate days. In this context, is justified the use of a device such as the recent Powerbreathe, which uses higher training loads that would provide greatest benefits, whereas the magnitude of the response to training tends to increase with load.

OBJECTIVE: To investigate the efficiency of high intensity IMT associated with combined aerobic and resistance training on maximal exercise capacity, submaximal exercise capacity, respiratory muscle strenght, pulmonary function, oxidative stress, quality of life and endothelial function in patients who underwent CABG in phase II cardiac rehabilitation program.

METHODOLOGY: This is a clinical trials, controlled, randomized,double-blind being developed in partnership with Cardiology Clinic of Hospital Universitário de Santa Maria (HUSM), Santa Maria, RS, Brazil. Patients will undergo the evaluation of pulmonary function and respiratory muscle strength (spirometry and digital manovacuometry), as well on the maximal exercise capacity (Ergospirometry), submaximal functional capacity (6MWT and 6MST), of quality of live (MLHFQ) of Oxidative stress and endothelial function (blood biomarkers). After the evaluation will be randomly allocated into two groups: the control group will perform cardiac rehabilitation associated with the Sham of IMT, and the experimental group cardiac rehabilitation associated with the IMT High-intensity. The intervention will last twelve weeks for both groups and after this phase patients will be submitted again to the assessment tools.

EXPECTED RESULTS: The high intensity IMT potentiates the effects of cardiac rehabilitation (phase II) after coronary artery bypass surgery patients.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date October 2018
Est. primary completion date August 2018
Accepts healthy volunteers No
Gender All
Age group 45 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients undergoing CABG up to three weeks before the initiation of the study, a clinical course without complications during hospitalization

- Clinically stable

- The absence of smoking (previous or current).

Exclusion Criteria:

- Unstable angina

- Myocardial infarction and heart surgery up to three months before the survey;

- Chronic respiratory diseases

- Hemodynamic instability

- Orthopedic and neurological diseases that may preclude the achievement of the cardiopulmonary test and Cardiac Rehabilitation exercises

- Psychological and / or cognitive impairments that restrict them to respond to questionnaires.

Study Design


Related Conditions & MeSH terms

  • Complications Due to Coronary Artery Bypass Graft

Intervention

Device:
High-intensity IMT + combined exercise


Locations

Country Name City State
Brazil University Hospital of Santa Maria Santa Maria Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal de Santa Maria

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Effects of high-intensity inspiratory muscle training on the functional capacity assessed by cardiopulmonary exercise test (CPT) and measured by VO2 peak. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the inspiratory muscle endurance evaluated by using the traditional manovacuometry and the PowerBreathe device. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on lung function assessed by spirometry. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the submaximal functional assessed by six-minute walk test (6MWT) and measured with six minute walk distance. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the submaximal functional capacity assessed by six-minute step test (6MST) and measured with the number of steps. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the quality of life assessed by Minnesota Living with Heart Failure questionnaire (MLHFQ) The MLHFQ is a questionnaire validated for the Brazilian population, consisting of 21 questions regarding limitations frequently associated with the extent to which heart failure has affected patient's lives in the previous month. Each question is attributed a value from 0 (zero) to 5 (five), with the highest score indicating worse quality of life. The total score is calculated by adding the 21 items, with a possible interval between 0 and 105. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the oxidative stress assessed by analysis of advanced oxidation protein products (AOPP). Plasma levels of AOPP assessed by on automated analyzer Mindray® expressed as µmol/L. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the oxidative stress assessed by analysis of products of ferric reducing antioxidant power (FRAP). Plasma levels of FRAP assesssed by automated analyzer Mindray® expressed as µmol/L. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the endothelial function assessed by analysis of nitric oxide (NOx). Plasma levels of NOx assessed automated analyzer Mindray® expressed as µmol/L. Finalized study (12 weeks)
Secondary Effects of high-intensity inspiratory muscle training on the Inflammatory profile assessed by through ultra-sensitive C-reactive protein (us-CRP) on automated analyzer Mindray® expressed as mg/dL Finalized study (12 weeks)
See also
  Status Clinical Trial Phase
Completed NCT01436981 - Pharmacokinetics of Pavaverine After Intraluminal Administration N/A
Completed NCT01848886 - Neurological Complications Comparing Endoscopically vs. Open Harvest of the Radial Artery N/A
Completed NCT05585138 - Effects of Segmental Breathing Exercise in Patients Awaiting Coronary Artery Bypass Graft Surgery (CABG) N/A
Completed NCT02471456 - MACCE After Endoscopic Vein Harvest for CABG N/A
Terminated NCT02762331 - High Dose Vitamin C in Cardiac Surgery Patients Phase 1
Completed NCT01469676 - Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function N/A
Unknown status NCT01414049 - Patency-Coronary Trial N/A